nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.189	0.602	CbGaD
Cyclobenzaprine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.168	1	CrCrCtD
Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	0.125	0.398	CbGaD
Cyclobenzaprine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0445	0.135	CbGbCtD
Cyclobenzaprine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0241	0.073	CbGbCtD
Cyclobenzaprine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0216	0.0652	CbGbCtD
Cyclobenzaprine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0213	0.0643	CbGbCtD
Cyclobenzaprine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0199	0.0601	CbGbCtD
Cyclobenzaprine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.019	0.0575	CbGbCtD
Cyclobenzaprine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.019	0.0573	CbGbCtD
Cyclobenzaprine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.018	0.0543	CbGbCtD
Cyclobenzaprine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0173	0.0524	CbGbCtD
Cyclobenzaprine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0163	0.0494	CbGbCtD
Cyclobenzaprine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0157	0.0473	CbGbCtD
Cyclobenzaprine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0152	0.0458	CbGbCtD
Cyclobenzaprine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0137	0.0414	CbGbCtD
Cyclobenzaprine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0122	0.037	CbGbCtD
Cyclobenzaprine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0104	0.0314	CbGbCtD
Cyclobenzaprine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00996	0.0301	CbGbCtD
Cyclobenzaprine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00996	0.0301	CbGbCtD
Cyclobenzaprine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00942	0.0285	CbGbCtD
Cyclobenzaprine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00702	0.0212	CbGbCtD
Cyclobenzaprine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00642	0.0194	CbGbCtD
Cyclobenzaprine—HTR2A—arteriole—type 2 diabetes mellitus	0.00321	0.244	CbGeAlD
Cyclobenzaprine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00205	0.156	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00137	0.105	CbGeAlD
Cyclobenzaprine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00127	0.0968	CbGeAlD
Cyclobenzaprine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000992	0.0755	CbGeAlD
Cyclobenzaprine—HTR2A—artery—type 2 diabetes mellitus	0.00078	0.0593	CbGeAlD
Cyclobenzaprine—HTR2A—nerve—type 2 diabetes mellitus	0.000773	0.0589	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—type 2 diabetes mellitus	0.000658	0.0501	CbGeAlD
Cyclobenzaprine—HTR2A—retina—type 2 diabetes mellitus	0.00032	0.0244	CbGeAlD
Cyclobenzaprine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000271	0.0206	CbGeAlD
Cyclobenzaprine—HTR2A—kidney—type 2 diabetes mellitus	0.000265	0.0202	CbGeAlD
Cyclobenzaprine—CYP3A4—kidney—type 2 diabetes mellitus	0.000245	0.0187	CbGeAlD
Cyclobenzaprine—CYP2D6—kidney—type 2 diabetes mellitus	0.000241	0.0184	CbGeAlD
Cyclobenzaprine—CYP1A2—liver—type 2 diabetes mellitus	0.000214	0.0163	CbGeAlD
Cyclobenzaprine—Promethazine—CALM1—type 2 diabetes mellitus	0.000175	0.0656	CrCbGaD
Cyclobenzaprine—HTR2A—liver—type 2 diabetes mellitus	0.000168	0.0128	CbGeAlD
Cyclobenzaprine—CYP3A4—liver—type 2 diabetes mellitus	0.000155	0.0118	CbGeAlD
Cyclobenzaprine—CYP2D6—liver—type 2 diabetes mellitus	0.000153	0.0116	CbGeAlD
Cyclobenzaprine—Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.000119	0.0445	CrCbGaD
Cyclobenzaprine—Carbamazepine—ABCC2—type 2 diabetes mellitus	0.000111	0.0414	CrCbGaD
Cyclobenzaprine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000101	0.0378	CrCbGaD
Cyclobenzaprine—Olopatadine—CYP3A4—type 2 diabetes mellitus	9.32e-05	0.0349	CrCbGaD
Cyclobenzaprine—Vomiting—Glimepiride—type 2 diabetes mellitus	9.23e-05	0.000658	CcSEcCtD
Cyclobenzaprine—Hypotension—Valsartan—type 2 diabetes mellitus	9.23e-05	0.000658	CcSEcCtD
Cyclobenzaprine—Vision blurred—Losartan—type 2 diabetes mellitus	9.23e-05	0.000658	CcSEcCtD
Cyclobenzaprine—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.2e-05	0.000656	CcSEcCtD
Cyclobenzaprine—Constipation—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000655	CcSEcCtD
Cyclobenzaprine—Tremor—Losartan—type 2 diabetes mellitus	9.17e-05	0.000654	CcSEcCtD
Cyclobenzaprine—Rash—Glimepiride—type 2 diabetes mellitus	9.15e-05	0.000653	CcSEcCtD
Cyclobenzaprine—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.15e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Rash—Sitagliptin—type 2 diabetes mellitus	9.13e-05	0.000651	CcSEcCtD
Cyclobenzaprine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.12e-05	0.00065	CcSEcCtD
Cyclobenzaprine—Headache—Glimepiride—type 2 diabetes mellitus	9.1e-05	0.000648	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.08e-05	0.000647	CcSEcCtD
Cyclobenzaprine—Headache—Sitagliptin—type 2 diabetes mellitus	9.07e-05	0.000646	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9e-05	0.000642	CcSEcCtD
Cyclobenzaprine—Agitation—Losartan—type 2 diabetes mellitus	9e-05	0.000641	CcSEcCtD
Cyclobenzaprine—Oedema—Metformin—type 2 diabetes mellitus	9e-05	0.000641	CcSEcCtD
Cyclobenzaprine—Tinnitus—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000641	CcSEcCtD
Cyclobenzaprine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.00064	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.96e-05	0.000639	CcSEcCtD
Cyclobenzaprine—Angioedema—Losartan—type 2 diabetes mellitus	8.94e-05	0.000638	CcSEcCtD
Cyclobenzaprine—Insomnia—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000637	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000634	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.87e-05	0.000632	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.86e-05	0.000632	CcSEcCtD
Cyclobenzaprine—Chest pain—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000631	CcSEcCtD
Cyclobenzaprine—Myalgia—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000631	CcSEcCtD
Cyclobenzaprine—Shock—Metformin—type 2 diabetes mellitus	8.85e-05	0.000631	CcSEcCtD
Cyclobenzaprine—Insomnia—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000629	CcSEcCtD
Cyclobenzaprine—Malaise—Losartan—type 2 diabetes mellitus	8.83e-05	0.000629	CcSEcCtD
Cyclobenzaprine—Anxiety—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000629	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.82e-05	0.000629	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.81e-05	0.000628	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000628	CcSEcCtD
Cyclobenzaprine—Vertigo—Losartan—type 2 diabetes mellitus	8.79e-05	0.000627	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.79e-05	0.000627	CcSEcCtD
Cyclobenzaprine—Somnolence—Valsartan—type 2 diabetes mellitus	8.78e-05	0.000626	CcSEcCtD
Cyclobenzaprine—Syncope—Losartan—type 2 diabetes mellitus	8.78e-05	0.000626	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.76e-05	0.000625	CcSEcCtD
Cyclobenzaprine—Leukopenia—Losartan—type 2 diabetes mellitus	8.76e-05	0.000625	CcSEcCtD
Cyclobenzaprine—Discomfort—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000624	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.7e-05	0.00062	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.7e-05	0.00062	CcSEcCtD
Cyclobenzaprine—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.66e-05	0.000617	CcSEcCtD
Cyclobenzaprine—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.66e-05	0.000617	CcSEcCtD
Cyclobenzaprine—Palpitations—Losartan—type 2 diabetes mellitus	8.65e-05	0.000617	CcSEcCtD
Cyclobenzaprine—Nausea—Glimepiride—type 2 diabetes mellitus	8.62e-05	0.000615	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000614	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.6e-05	0.000613	CcSEcCtD
Cyclobenzaprine—Nausea—Sitagliptin—type 2 diabetes mellitus	8.6e-05	0.000613	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.59e-05	0.000613	CcSEcCtD
Cyclobenzaprine—Asthenia—Glyburide—type 2 diabetes mellitus	8.59e-05	0.000612	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.59e-05	0.000612	CcSEcCtD
Cyclobenzaprine—Anorexia—Metformin—type 2 diabetes mellitus	8.57e-05	0.000611	CcSEcCtD
Cyclobenzaprine—Urticaria—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.000609	CcSEcCtD
Cyclobenzaprine—Alopecia—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000607	CcSEcCtD
Cyclobenzaprine—Fatigue—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000607	CcSEcCtD
Cyclobenzaprine—Alimemazine—CYP3A4—type 2 diabetes mellitus	8.51e-05	0.0318	CrCbGaD
Cyclobenzaprine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.5e-05	0.000606	CcSEcCtD
Cyclobenzaprine—Oedema—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000605	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000605	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.48e-05	0.000605	CcSEcCtD
Cyclobenzaprine—Pruritus—Glyburide—type 2 diabetes mellitus	8.47e-05	0.000604	CcSEcCtD
Cyclobenzaprine—Constipation—Valsartan—type 2 diabetes mellitus	8.45e-05	0.000602	CcSEcCtD
Cyclobenzaprine—Fatigue—Orlistat—type 2 diabetes mellitus	8.42e-05	0.0006	CcSEcCtD
Cyclobenzaprine—Hypotension—Metformin—type 2 diabetes mellitus	8.41e-05	0.000599	CcSEcCtD
Cyclobenzaprine—Shock—Irbesartan—type 2 diabetes mellitus	8.35e-05	0.000595	CcSEcCtD
Cyclobenzaprine—Chest pain—Losartan—type 2 diabetes mellitus	8.33e-05	0.000594	CcSEcCtD
Cyclobenzaprine—Myalgia—Losartan—type 2 diabetes mellitus	8.33e-05	0.000594	CcSEcCtD
Cyclobenzaprine—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.33e-05	0.000594	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000593	CcSEcCtD
Cyclobenzaprine—Anxiety—Losartan—type 2 diabetes mellitus	8.3e-05	0.000592	CcSEcCtD
Cyclobenzaprine—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000591	CcSEcCtD
Cyclobenzaprine—Rash—Bromocriptine—type 2 diabetes mellitus	8.26e-05	0.000589	CcSEcCtD
Cyclobenzaprine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.25e-05	0.000588	CcSEcCtD
Cyclobenzaprine—Trimipramine—ADRA2A—type 2 diabetes mellitus	8.24e-05	0.0308	CrCbGaD
Cyclobenzaprine—Tension—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Discomfort—Losartan—type 2 diabetes mellitus	8.23e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000586	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	8.21e-05	0.0307	CrCbGaD
Cyclobenzaprine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000585	CcSEcCtD
Cyclobenzaprine—Headache—Bromocriptine—type 2 diabetes mellitus	8.21e-05	0.000585	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ABCC2—type 2 diabetes mellitus	8.2e-05	0.0307	CrCbGaD
Cyclobenzaprine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.2e-05	0.000584	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.19e-05	0.000584	CcSEcCtD
Cyclobenzaprine—Nervousness—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000581	CcSEcCtD
Cyclobenzaprine—Dry mouth—Losartan—type 2 diabetes mellitus	8.15e-05	0.000581	CcSEcCtD
Cyclobenzaprine—Anorexia—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000577	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000576	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Metformin—type 2 diabetes mellitus	8.08e-05	0.000576	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR2C—type 2 diabetes mellitus	8.06e-05	0.0301	CrCbGaD
Cyclobenzaprine—Confusional state—Losartan—type 2 diabetes mellitus	8.06e-05	0.000574	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.04e-05	0.000573	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Metformin—type 2 diabetes mellitus	8.02e-05	0.000572	CcSEcCtD
Cyclobenzaprine—Somnolence—Metformin—type 2 diabetes mellitus	8e-05	0.00057	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.99e-05	0.00057	CcSEcCtD
Cyclobenzaprine—Oedema—Losartan—type 2 diabetes mellitus	7.99e-05	0.00057	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.98e-05	0.000569	CcSEcCtD
Cyclobenzaprine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.93e-05	0.000565	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000565	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.92e-05	0.000564	CcSEcCtD
Cyclobenzaprine—Tremor—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000561	CcSEcCtD
Cyclobenzaprine—Shock—Losartan—type 2 diabetes mellitus	7.86e-05	0.00056	CcSEcCtD
Cyclobenzaprine—Doxepin—ADRA2A—type 2 diabetes mellitus	7.85e-05	0.0294	CrCbGaD
Cyclobenzaprine—Urticaria—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000559	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.82e-05	0.000558	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Metformin—type 2 diabetes mellitus	7.82e-05	0.000557	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000557	CcSEcCtD
Cyclobenzaprine—Tachycardia—Losartan—type 2 diabetes mellitus	7.8e-05	0.000556	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000555	CcSEcCtD
Cyclobenzaprine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.78e-05	0.000555	CcSEcCtD
Cyclobenzaprine—Fatigue—Metformin—type 2 diabetes mellitus	7.76e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Urticaria—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000551	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.72e-05	0.000551	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.72e-05	0.00055	CcSEcCtD
Cyclobenzaprine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.00055	CcSEcCtD
Cyclobenzaprine—Agitation—Ramipril—type 2 diabetes mellitus	7.71e-05	0.00055	CcSEcCtD
Cyclobenzaprine—Constipation—Metformin—type 2 diabetes mellitus	7.69e-05	0.000548	CcSEcCtD
Cyclobenzaprine—Angioedema—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000547	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000543	CcSEcCtD
Cyclobenzaprine—Anorexia—Losartan—type 2 diabetes mellitus	7.62e-05	0.000543	CcSEcCtD
Cyclobenzaprine—Vomiting—Glyburide—type 2 diabetes mellitus	7.61e-05	0.000543	CcSEcCtD
Cyclobenzaprine—Pruritus—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.000542	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR2C—type 2 diabetes mellitus	7.58e-05	0.0284	CrCbGaD
Cyclobenzaprine—Malaise—Ramipril—type 2 diabetes mellitus	7.57e-05	0.00054	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.00054	CcSEcCtD
Cyclobenzaprine—Rash—Glyburide—type 2 diabetes mellitus	7.55e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Somnolence—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Dermatitis—Glyburide—type 2 diabetes mellitus	7.54e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Vertigo—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Syncope—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000537	CcSEcCtD
Cyclobenzaprine—Leukopenia—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Headache—Glyburide—type 2 diabetes mellitus	7.5e-05	0.000535	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000533	CcSEcCtD
Cyclobenzaprine—Hypotension—Losartan—type 2 diabetes mellitus	7.46e-05	0.000532	CcSEcCtD
Cyclobenzaprine—Palpitations—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000529	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.41e-05	0.000528	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	7.38e-05	0.0276	CrCbGaD
Cyclobenzaprine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000526	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000526	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.36e-05	0.000524	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.36e-05	0.000524	CcSEcCtD
Cyclobenzaprine—Fatigue—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000522	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.28e-05	0.000519	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.28e-05	0.000519	CcSEcCtD
Cyclobenzaprine—Convulsion—Ramipril—type 2 diabetes mellitus	7.27e-05	0.000518	CcSEcCtD
Cyclobenzaprine—Constipation—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000518	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR2C—type 2 diabetes mellitus	7.23e-05	0.027	CrCbGaD
Cyclobenzaprine—Insomnia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000515	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000513	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Losartan—type 2 diabetes mellitus	7.17e-05	0.000511	CcSEcCtD
Cyclobenzaprine—Urticaria—Metformin—type 2 diabetes mellitus	7.15e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Chest pain—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Myalgia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Losartan—type 2 diabetes mellitus	7.12e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Anxiety—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Nausea—Glyburide—type 2 diabetes mellitus	7.11e-05	0.000507	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Metformin—type 2 diabetes mellitus	7.11e-05	0.000507	CcSEcCtD
Cyclobenzaprine—Dizziness—Gliclazide—type 2 diabetes mellitus	7.11e-05	0.000507	CcSEcCtD
Cyclobenzaprine—Somnolence—Losartan—type 2 diabetes mellitus	7.1e-05	0.000506	CcSEcCtD
Cyclobenzaprine—Asthenia—Valsartan—type 2 diabetes mellitus	7.09e-05	0.000505	CcSEcCtD
Cyclobenzaprine—Discomfort—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000503	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Losartan—type 2 diabetes mellitus	7.03e-05	0.000501	CcSEcCtD
Cyclobenzaprine—Asthenia—Orlistat—type 2 diabetes mellitus	7e-05	0.000499	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7e-05	0.000499	CcSEcCtD
Cyclobenzaprine—Pruritus—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000498	CcSEcCtD
Cyclobenzaprine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000498	CcSEcCtD
Cyclobenzaprine—Promazine—ADRA2A—type 2 diabetes mellitus	6.98e-05	0.0261	CrCbGaD
Cyclobenzaprine—Decreased appetite—Losartan—type 2 diabetes mellitus	6.94e-05	0.000495	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000495	CcSEcCtD
Cyclobenzaprine—Confusional state—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000492	CcSEcCtD
Cyclobenzaprine—Pruritus—Orlistat—type 2 diabetes mellitus	6.91e-05	0.000492	CcSEcCtD
Cyclobenzaprine—Fatigue—Losartan—type 2 diabetes mellitus	6.89e-05	0.000491	CcSEcCtD
Cyclobenzaprine—Oedema—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000488	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000488	CcSEcCtD
Cyclobenzaprine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.000487	CcSEcCtD
Cyclobenzaprine—Constipation—Losartan—type 2 diabetes mellitus	6.83e-05	0.000487	CcSEcCtD
Cyclobenzaprine—Rash—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000483	CcSEcCtD
Cyclobenzaprine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.77e-05	0.000483	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.76e-05	0.000482	CcSEcCtD
Cyclobenzaprine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000481	CcSEcCtD
Cyclobenzaprine—Shock—Ramipril—type 2 diabetes mellitus	6.74e-05	0.00048	CcSEcCtD
Cyclobenzaprine—Headache—Gliclazide—type 2 diabetes mellitus	6.74e-05	0.00048	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000478	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000478	CcSEcCtD
Cyclobenzaprine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000477	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.68e-05	0.000476	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000472	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.58e-05	0.000469	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.53e-05	0.000466	CcSEcCtD
Cyclobenzaprine—Dizziness—Valsartan—type 2 diabetes mellitus	6.53e-05	0.000466	CcSEcCtD
Cyclobenzaprine—Anorexia—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000465	CcSEcCtD
Cyclobenzaprine—Dizziness—Orlistat—type 2 diabetes mellitus	6.45e-05	0.00046	CcSEcCtD
Cyclobenzaprine—Asthenia—Metformin—type 2 diabetes mellitus	6.45e-05	0.00046	CcSEcCtD
Cyclobenzaprine—Promazine—HTR2C—type 2 diabetes mellitus	6.42e-05	0.024	CrCbGaD
Cyclobenzaprine—Hypotension—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000456	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	6.39e-05	0.0239	CrCbGaD
Cyclobenzaprine—Nausea—Gliclazide—type 2 diabetes mellitus	6.39e-05	0.000455	CcSEcCtD
Cyclobenzaprine—Pruritus—Metformin—type 2 diabetes mellitus	6.36e-05	0.000454	CcSEcCtD
Cyclobenzaprine—Urticaria—Losartan—type 2 diabetes mellitus	6.35e-05	0.000452	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Losartan—type 2 diabetes mellitus	6.32e-05	0.00045	CcSEcCtD
Cyclobenzaprine—Vomiting—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000448	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000446	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000445	CcSEcCtD
Cyclobenzaprine—Rash—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000444	CcSEcCtD
Cyclobenzaprine—Dermatitis—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000444	CcSEcCtD
Cyclobenzaprine—Vomiting—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000442	CcSEcCtD
Cyclobenzaprine—Insomnia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000442	CcSEcCtD
Cyclobenzaprine—Headache—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000441	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Metformin—type 2 diabetes mellitus	6.15e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Rash—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Dermatitis—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000438	CcSEcCtD
Cyclobenzaprine—Headache—Orlistat—type 2 diabetes mellitus	6.11e-05	0.000436	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000435	CcSEcCtD
Cyclobenzaprine—Asthenia—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000434	CcSEcCtD
Cyclobenzaprine—Somnolence—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000434	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	6.08e-05	0.0227	CrCbGaD
Cyclobenzaprine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	6.07e-05	0.0227	CrCbGaD
Cyclobenzaprine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.03e-05	0.00043	CcSEcCtD
Cyclobenzaprine—Pruritus—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000428	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000425	CcSEcCtD
Cyclobenzaprine—Dizziness—Metformin—type 2 diabetes mellitus	5.95e-05	0.000424	CcSEcCtD
Cyclobenzaprine—Fatigue—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000421	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.89e-05	0.00042	CcSEcCtD
Cyclobenzaprine—Nausea—Valsartan—type 2 diabetes mellitus	5.87e-05	0.000418	CcSEcCtD
Cyclobenzaprine—Constipation—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000418	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000414	CcSEcCtD
Cyclobenzaprine—Nausea—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000413	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	5.75e-05	0.0215	CrCbGaD
Cyclobenzaprine—Asthenia—Losartan—type 2 diabetes mellitus	5.73e-05	0.000409	CcSEcCtD
Cyclobenzaprine—Vomiting—Metformin—type 2 diabetes mellitus	5.72e-05	0.000408	CcSEcCtD
Cyclobenzaprine—Rash—Metformin—type 2 diabetes mellitus	5.67e-05	0.000404	CcSEcCtD
Cyclobenzaprine—Dermatitis—Metformin—type 2 diabetes mellitus	5.67e-05	0.000404	CcSEcCtD
Cyclobenzaprine—Pruritus—Losartan—type 2 diabetes mellitus	5.65e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000402	CcSEcCtD
Cyclobenzaprine—Headache—Metformin—type 2 diabetes mellitus	5.64e-05	0.000402	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR2C—type 2 diabetes mellitus	5.63e-05	0.021	CrCbGaD
Cyclobenzaprine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	5.62e-05	0.021	CrCbGaD
Cyclobenzaprine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.0004	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000399	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR2C—type 2 diabetes mellitus	5.59e-05	0.0209	CrCbGaD
Cyclobenzaprine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	5.59e-05	0.0209	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	5.47e-05	0.0205	CrCbGaD
Cyclobenzaprine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.47e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Doxepin—CYP1A2—type 2 diabetes mellitus	5.45e-05	0.0204	CrCbGaD
Cyclobenzaprine—Urticaria—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000386	CcSEcCtD
Cyclobenzaprine—Vomiting—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000385	CcSEcCtD
Cyclobenzaprine—Rash—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000382	CcSEcCtD
Cyclobenzaprine—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000381	CcSEcCtD
Cyclobenzaprine—Nausea—Metformin—type 2 diabetes mellitus	5.34e-05	0.000381	CcSEcCtD
Cyclobenzaprine—Headache—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000379	CcSEcCtD
Cyclobenzaprine—Dizziness—Losartan—type 2 diabetes mellitus	5.28e-05	0.000377	CcSEcCtD
Cyclobenzaprine—Vomiting—Losartan—type 2 diabetes mellitus	5.08e-05	0.000362	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.05e-05	0.00036	CcSEcCtD
Cyclobenzaprine—Nausea—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000359	CcSEcCtD
Cyclobenzaprine—Rash—Losartan—type 2 diabetes mellitus	5.04e-05	0.000359	CcSEcCtD
Cyclobenzaprine—Dermatitis—Losartan—type 2 diabetes mellitus	5.03e-05	0.000359	CcSEcCtD
Cyclobenzaprine—Headache—Losartan—type 2 diabetes mellitus	5e-05	0.000357	CcSEcCtD
Cyclobenzaprine—Asthenia—Ramipril—type 2 diabetes mellitus	4.91e-05	0.00035	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	4.89e-05	0.0183	CrCbGaD
Cyclobenzaprine—Promazine—CYP1A2—type 2 diabetes mellitus	4.85e-05	0.0181	CrCbGaD
Cyclobenzaprine—Pruritus—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000346	CcSEcCtD
Cyclobenzaprine—Nausea—Losartan—type 2 diabetes mellitus	4.75e-05	0.000338	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000334	CcSEcCtD
Cyclobenzaprine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	4.64e-05	0.0174	CrCbGaD
Cyclobenzaprine—Dizziness—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000323	CcSEcCtD
Cyclobenzaprine—Imipramine—CYP2E1—type 2 diabetes mellitus	4.46e-05	0.0167	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	4.43e-05	0.0166	CrCbGaD
Cyclobenzaprine—Vomiting—Ramipril—type 2 diabetes mellitus	4.36e-05	0.00031	CcSEcCtD
Cyclobenzaprine—Rash—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000308	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000308	CcSEcCtD
Cyclobenzaprine—Headache—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000306	CcSEcCtD
Cyclobenzaprine—Imipramine—CYP1A2—type 2 diabetes mellitus	4.24e-05	0.0159	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	4.22e-05	0.0158	CrCbGaD
Cyclobenzaprine—Nausea—Ramipril—type 2 diabetes mellitus	4.07e-05	0.00029	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	4.02e-05	0.0151	CrCbGaD
Cyclobenzaprine—Trimipramine—CYP3A4—type 2 diabetes mellitus	3.79e-05	0.0142	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.0136	CrCbGaD
Cyclobenzaprine—Doxepin—CYP3A4—type 2 diabetes mellitus	3.61e-05	0.0135	CrCbGaD
Cyclobenzaprine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	3.52e-05	0.0132	CrCbGaD
Cyclobenzaprine—Nortriptyline—ALB—type 2 diabetes mellitus	3.51e-05	0.0131	CrCbGaD
Cyclobenzaprine—Promazine—CYP3A4—type 2 diabetes mellitus	3.21e-05	0.012	CrCbGaD
Cyclobenzaprine—Imipramine—CYP3A4—type 2 diabetes mellitus	2.81e-05	0.0105	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	2.79e-05	0.0104	CrCbGaD
Cyclobenzaprine—Amitriptyline—ALB—type 2 diabetes mellitus	2.44e-05	0.00911	CrCbGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	8.55e-06	0.000272	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	8.55e-06	0.000272	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	8.55e-06	0.000272	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.52e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.52e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.52e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.47e-06	0.00027	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.4e-06	0.000268	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.36e-06	0.000266	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.33e-06	0.000265	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.32e-06	0.000265	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.26e-06	0.000263	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	8.2e-06	0.000261	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.18e-06	0.00026	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.15e-06	0.000259	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.15e-06	0.000259	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.05e-06	0.000256	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	8.01e-06	0.000255	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.93e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.93e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.89e-06	0.000251	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.82e-06	0.000249	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.73e-06	0.000246	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.69e-06	0.000245	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	7.62e-06	0.000243	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.58e-06	0.000241	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.54e-06	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.5e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.49e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.45e-06	0.000237	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	7.45e-06	0.000237	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.38e-06	0.000235	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.38e-06	0.000235	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.38e-06	0.000235	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.33e-06	0.000233	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.31e-06	0.000233	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.24e-06	0.000231	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.24e-06	0.000231	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.24e-06	0.000231	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.24e-06	0.000231	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.12e-06	0.000227	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.07e-06	0.000225	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.07e-06	0.000225	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.97e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.97e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.97e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.97e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.94e-06	0.000221	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.85e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.84e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.84e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.81e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.81e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.79e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.79e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.79e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.75e-06	0.000215	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.75e-06	0.000215	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.69e-06	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.63e-06	0.000211	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.61e-06	0.00021	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.58e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.58e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.58e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.55e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.53e-06	0.000208	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.48e-06	0.000206	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.46e-06	0.000206	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.42e-06	0.000204	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	6.34e-06	0.000202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.34e-06	0.000202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.31e-06	0.000201	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.28e-06	0.0002	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.22e-06	0.000198	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.18e-06	0.000197	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	6.12e-06	0.000195	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.1e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.09e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.09e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.09e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.03e-06	0.000192	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.03e-06	0.000192	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.98e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.93e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.91e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.91e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	5.85e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.8e-06	0.000185	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.79e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.79e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.76e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.75e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.75e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.75e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.72e-06	0.000182	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.72e-06	0.000182	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.62e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.59e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.59e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.59e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.59e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.57e-06	0.000177	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.55e-06	0.000177	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.51e-06	0.000175	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.51e-06	0.000175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.49e-06	0.000175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.39e-06	0.000172	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.37e-06	0.000171	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.36e-06	0.000171	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.28e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.28e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	5.26e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.18e-06	0.000165	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.16e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.16e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.16e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.07e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.02e-06	0.00016	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.02e-06	0.00016	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.01e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	5e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.98e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.95e-06	0.000158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.92e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.91e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.9e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.9e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.84e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.72e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.67e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.65e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.62e-06	0.000147	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.56e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.56e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.55e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.55e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.55e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.53e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.53e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.48e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.48e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.47e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.47e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.44e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.44e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.44e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.41e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.37e-06	0.000139	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.34e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.33e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.28e-06	0.000136	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.22e-06	0.000134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.19e-06	0.000133	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.15e-06	0.000132	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.12e-06	0.000131	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.06e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.05e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.05e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.04e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.03e-06	0.000128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.98e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.98e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.98e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.94e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.91e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.89e-06	0.000124	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.88e-06	0.000123	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.86e-06	0.000123	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.86e-06	0.000123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.85e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.84e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.79e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.73e-06	0.000119	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.68e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.67e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.67e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.66e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-06	0.000116	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.6e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.58e-06	0.000114	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.55e-06	0.000113	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.51e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.49e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.47e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.46e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.45e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.44e-06	0.000109	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.43e-06	0.000109	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.43e-06	0.000109	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.34e-06	0.000106	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.29e-06	0.000105	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.16e-06	0.000101	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.15e-06	0.0001	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.12e-06	9.93e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.1e-06	9.88e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.1e-06	9.86e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.03e-06	9.64e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3e-06	9.57e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-06	9.48e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-06	9.48e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.97e-06	9.45e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-06	9.44e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.95e-06	9.41e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.95e-06	9.38e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	9.37e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.92e-06	9.31e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.91e-06	9.28e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-06	9.27e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.86e-06	9.1e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.84e-06	9.04e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-06	8.79e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.72e-06	8.67e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.72e-06	8.65e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.71e-06	8.63e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-06	8.45e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.65e-06	8.42e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	8.42e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.6e-06	8.29e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.6e-06	8.29e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.58e-06	8.2e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	8.16e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-06	8.1e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	8.01e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-06	7.77e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.43e-06	7.73e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	7.62e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.38e-06	7.58e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.38e-06	7.58e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.32e-06	7.38e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.31e-06	7.34e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-06	7.26e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.27e-06	7.23e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-06	7.15e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-06	7.02e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-06	7.02e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	6.42e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	6.3e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.94e-06	6.18e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.83e-06	5.83e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	5.67e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	5.42e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	5.42e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.69e-06	5.37e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	4.96e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.2e-06	3.81e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	3.23e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.82e-07	2.49e-05	CbGpPWpGaD
